Upstream Bio (UPB) Net Margin (2023 - 2026)

Upstream Bio's quarterly Net Margin came in at 3922.73% in Q1 2026, up 89529.0% year-on-year from N/an in Q1 2025, and up 38.28% quarter-over-quarter from 6356.14% in Q4 2025.

Upstream Bio has reported Net Margin for 4 years, with the latest figure at 3922.73% in Q1 2026.

  • For the quarter ending Q1 2026, Net Margin rose 89529.0% year-over-year to 3922.73%; the trailing twelve-month figure through Mar 2026 stood at 4718.06% (down 81323.0% YoY), and the FY2025 full-year result was 5026.03%, down 180262.0% from the prior year.
  • Net Margin for Q1 2026 stood at 3922.73%, up from 6356.14% in the prior quarter.
  • The five-year high for Net Margin was 1006.92% in Q3 2023, with the low at 6356.14% in Q4 2025.
  • Average Net Margin over 4 years is 3789.5%, with a median of 3835.69% recorded in 2024.
  • Year-over-year, Net Margin plunged 280149 bps in 2025 and jumped 89529 bps in 2026.
  • Tracing UPB's Net Margin over 4 years: stood at 3329.78% in 2023, then slipped by 7 bps to 3554.65% in 2024, then plunged by 79 bps to 6356.14% in 2025, then surged by 38 bps to 3922.73% in 2026.
  • The last three Net Margin figures came in at 3922.73% (Q1 2026), 6356.14% (Q4 2025), and 4941.14% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 0.82%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 34.53%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 20.17%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 17.65%
10 Upstream Bio 454.22 Mn 454.22 Mn -3.94 Mn -3,922.73%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -3,922.73%
Dec 31, 2025 -6,356.14%
Sep 30, 2025 -4,941.14%
Jun 30, 2025 -4,265.31%
Mar 31, 2025 -4,818.02%
Dec 31, 2024 -3,554.65%
Sep 30, 2024 -3,465.07%
Jun 30, 2024 -3,835.69%
Mar 31, 2024 -2,189.06%
Dec 31, 2023 -3,329.78%
Sep 30, 2023 -1,006.92%